icd 10 code for test fibrosure

Full Answer

What is the ICD 10 code for hepatic fibrosis?

Hepatic fibrosis. 2016 2017 2018 2019 2020 Billable/Specific Code. K74.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM K74.0 became effective on October 1, 2019.

What are the limitations of the Gilbert test for fibrosis?

It is also not recommended in patients with Gilbert disease, acute hemolysis, acute hepatitis, acute inflammation of the liver, autoimmune hepatitis, extrahepatic cholestasis, transplant patients, and/or renal insufficiency patients. Any of these clinical situations may lead to inaccurate quantitative predictions of fibrosis.

Do biomarkers for the prediction of liver fibrosis require FDA clearance or approval?

The FDA has determined that such clearance or approval is not necessary. Naveau S, Raynard B, Ratziu V, et al. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease.

How are The FibroTest and ActiTest scores calculated?

The FibroTest and ActiTest scores are calculated based on patient age, gender and concentrations of serum of y-glutamyl transferase (GGT), total bilirubin (TB), a-2 macroglobulin, haptoglobin, apolipoprotein A1 and alanine aminotransferase (ActiTest).

What is a FibroSure test?

HCV FibroSure® is a noninvasive blood test of 6 biochemical. markers that provides METAVIR fibrosis staging and. necroinflammatory grading.

What is a Nash FibroSure test?

NASH FibroSure® is a noninvasive assessment of liver status in patients with nonalcoholic fatty liver disease (NAFLD). It is not recommended for patient with other liver diseases.

Is FibroSure covered by insurance?

Coverage is subject to the specific terms of the member's benefit plan. The FibroSure test to assess liver fibrosis is considered experimental/investigational, and therefore, non-covered because the safety and/or effectiveness of this service cannot be established by the available published peer-reviewed literature.

What is Ash FibroSure test?

The ASH FibroSURE test is a non-invasive risk stratification for suspected alcoholic liver disease by quantifying liver fibrosis, steatosis and alcoholic steatohepatitis. It is recommended for chronic alcohol consumers to assess pre-cirrhotic status.

Does Medicare cover FibroSURE test?

Medicare HMO BlueSM and Medicare PPO BlueSM Members A single FibroSURE multianalyte assay may be considered MEDICALLY NECESSARY for the evaluation of patients with chronic liver disease. FibroSURE multianalyte assays are considered INVESTIGATIONAL for monitoring of patients with chronic liver disease.

How accurate is FibroSURE blood test?

Results. The testing algorithm using Fibrosure was the most accurate noninvasive strategy with a sensitivity, specificity, and overall accuracy of 84%, 87%, and 86%, respectively.

What is the CPT code for a FibroScan?

FibroScan® Testing is Covered Under Category I CPT Code 91200.

How do you read a FibroSure?

All FibroSure tests are performed and interpreted by LabCorp....FibroSURE.Fibrosis ScoreMETAVIRComment0.31 – 0.48Stage F1 – F20.48 – 0.58Stage F2Bridging fibrosis few septa0.58 – 0.72Stage F3Bridging fibrosis many septa0.72 – 0.74Stage F3 – F412 more rows

How accurate is NASH FibroSure test?

The NASH FibroSure test is reported to have a sensitivity of 83% and a specificity of 78% in detecting risk of significant fibrosis and a sensitivity of 71% and a specificity of 72% in identifying risk of significant steatosis in patients with NAFLD.

How do you read FibroScan results?

Read across the row from left to right until you find the range that includes your fibrosis result. Then, look at the top of that column to see the fibrosis score. Your fibrosis result may be over-estimated (your liver may have less scarring than what your fibrosis result says) if you have: Liver inflammation.

Is FibroSURE FDA approved?

It has not been cleared or approved by the US Food and Drug Administration (FDA).

How FibroScan test is done?

Fibroscan takes about 15 minutes to complete, and it is not painful. Some gel will be placed on your skin, between your ribs on your right side. A small probe will then be gently moved across your skin to analyze whether there is any fibrosis in your liver.

How long after diagnosis of HCV can you assess liver status?

Baseline determination of liver status before initiating HCV therapy. Posttreatment assessment of liver status six months after completion of therapy. Noninvasive assessment of liver status in patients who are at increased risk of complications from a liver biopsy.

Is LabCorp a FDA approved test?

This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA). The FDA has determined that such clearance or approval is not necessary.

What is a Metavir F0-F4?

Quantitative results of 10 biochemicals in combination with age, gender, height, and weight are analyzed using a computational algorithm to provide a quantitative surrogate marker (0.0-1.0) of liver fibrosis (Metavir F0-F4), hepatic steatosis (0.0-1.0, S0-S3), and alcoholic steatohepatitis (ASH) (0.0-1.0, H0-H3).

Is ASH Fibrosure safe for liver disease?

ASH FibroSure® is recommended for patients with suspected alcoholic liver disease. It is not recommended for patients with other liver diseases. It is also not recommended in patients with Gilbert disease, acute hemolysis, acute hepatitis, acute inflammation of the liver, extrahepatic cholestasis, transplant patients, and/or renal insufficiency patients. Any of these clinical situations may lead to inaccurate quantitative predictions of fibrosis.

Assay Category

This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Collection Instructions

Serum should be separated from the cells as soon as possible after visible clot formation (usually 15-30 minutes after collection). Avoid freezing and thawing.

Reject Criteria

Gross hemolysis • Grossly lipemic • Patients <2 years old • QNS for one or more analytes

Setup Schedule

Serum should be separated from the cells as soon as possible after visible clot formation (usually 15-30 minutes after collection). Avoid freezing and thawing.